The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Vol. 52. Issue 1.
Pages 71-72 (1 January 2000)
Vol. 52. Issue 1.
Pages 71-72 (1 January 2000)
Full text access
Las inmunoglobulinas en la profilaxis de la varicela
Visits
19202
This item has received
Article information
Full text is only available in PDF
Bibliografía
[1.]
J. Ruiz Contreras, J. De Arístegui Fernández, M. Bernacer Borja, J. Sánchez de Toledo Codina.
Recomendaciones de uso de la vacuna antivaricela en niños inmunocomprometidos.
An Esp Pediatr, 50 (1999), pp. 113-118
[2.]
American Society of Health-System Pharmacists, Inc. ImmuneGlobulin.
Drug Information, pp. 2543
[3.]
M. Martorell, M. Oliveras, C. Juste, M.T. López, M.J. Cabañas, C. Barroso.
octubre, (1995),
[4.]
S.G. Paryani, A.M. Arvin, C.M. Koropchack, A.E. Wittek, M.D. Amylon, M.B. Dobkin.
Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
Am J Med, 76 (1984), pp. 124-127
Copyright © 2000. Asociación Española de Pediatría


